Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis

Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008

(2014) A. Fournier et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis

(2014) Jianli Zhao et al.   BREAST CANCER RESEARCH AND TREATMENT

Reproductive risk factors and breast cancer subtypes: a review of the literature

(2014) Kristin N. Anderson et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: A comparative study in 363 patients

(2014) C. Ngô et al.   EJSO

Endometrial cancer: A review and current management strategies: Part I

(2014) William M. Burke et al.   GYNECOLOGIC ONCOLOGY

Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study

(2014) Ju-Yin Chen et al.   Journal of Cancer

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study

(2013) Yakir Segev et al.   GYNECOLOGIC ONCOLOGY

Declining Second Primary Ovarian Cancer After First Primary Breast Cancer

(2013) Sara J. Schonfeld et al.   JOURNAL OF CLINICAL ONCOLOGY

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors

(2011) Madiha F. Abdel-Maksoud et al.   BREAST CANCER RESEARCH AND TREATMENT

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

(2010) Sandra M. Swain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

(2009) Shuzhen Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial

(2008) Sandra M. Swain et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study

(2008) Michael Schaapveld et al.   JOURNAL OF CLINICAL ONCOLOGY

Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?

(2008) Leen De Maeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET